regenerative-medicine
Telangiectasias (from Greek, meaning 'dilation of vessel endings') are dilated capillaries and small blood vessels visible on the skin surface. These vascular manifestations affect both men and women, with documented higher prevalence in females and increasing occurrence with age. Beyond cosmetic concerns, when accompanied by symptoms, they may represent the initial stage of chronic venous disease, as stated in the latest guidelines of the Italian Society of Phlebology (SIF).
Various predisposing factors including genetics, family history, prolonged standing, and estrogen-progestin medications contribute to venous wall deterioration. The venous wall becomes less elastic and venous valves less competent, reducing the efficiency of blood return to the right atrium. This functional deficit leads to reflux and blood volume accumulation in the lower extremity venous circulation, resulting in increased venous pressure and collateral vessel dilation. Clinical manifestations include leg fatigue, visible capillaries, prominent veins, and in severe cases, varicose veins.
TRAP (Three-dimensional Regenerative Ambulatory Phlebotherapy) addresses the entire superficial and perforating venous system affected by intrinsic wall weakness. The procedure involves endovenous injection of precisely diluted sodium salicylate solution administered over multiple sessions. Veins are visualized using transillumination technology.
The treatment aims to restore proper consistency and linear flow to thinned, inflamed, and weakened vein walls while recovering valvular competence to promote proper blood circulation. Comprehensive treatment of the entire circulatory system is essential to prevent recurrence.
Post-treatment compression therapy (140 denier stockings) is required between sessions and for one month after completing the therapeutic cycle. The procedure does not restrict physical or social activities. Treatments are optimally performed during autumn and winter months, treating one limb at a time.